News
United Kingdom Registration of New TyraTech Naturals® Insect Repellent Product
04 March 2013
Field Trials Demonstrate Superior Performance Over Current Market Leading Products
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, is pleased to announce that the Company has been granted permission to sell its new personal insect repellent in the United Kingdom. This means that the product is approved and ready for immediate commercialization in retail channels. NO-SKEETO!™ features TyraTech's Nature's Technology™ platform which harnesses the power of natural ingredients to deliver best-in-class efficacy and family safety.
Both Laboratory and Field trials have demonstrated that NO-SKEETO!™ significantly outperforms 15% DEET for both mosquito and tick repellency. Trials have been carried out using various species of mosquito including those which are known vectors of West Nile Virus, Malaria, Dengue fever, yellow fever and St Louis encephalitis. Tick trials have included species which are vectors for Lyme disease, Rocky Mountain spotted fever and Southern tick associated rash infection (STARI).
The Company has filed for patent protection for its NO-SKEETO!™ formulation and has submitted data from the laboratory and field trials for publication in two international journals. The Company has already been granted registration for NO-SKEETO!™ in the U.S. and German markets.
David Paton, TyraTech's Head of European Operations, said "NO-SKEETO!™ provides an effective and timely solution for families seeking superior protection without concerns over safety. Our portfolio of European registrations is expected to continue to grow in the coming months. We are currently in the process of evaluating commercial and retail partners for this product and for our other products."
Further information on NO-SKEETO!™ is available on the Company's website at www.tyratech.com/RepellentTechnologyOverview
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
+1 919 415 4310
Bruno Jactel Chief Executive Officer
+1 919 415 4340
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 7496 3000
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford /Helen Westaway (Public Relations)
Tel + 44 7933 8792
tyratech@walbrookpr.com
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.